News

It should suffice to say that obtaining informed consent is required ethically and legally in almost all forms of human research in almost all countries.

Efforts by drug companies to streamline and improve the execution of clinical study designs-to counter mounting costs and shorten development times associated with bringing new drugs to market-are yielding positive benefits.

Efforts by drug companies to streamline and improve the execution of clinical study designs-to counter mounting costs and shorten development times associated with bringing new drugs to market-are yielding positive benefits.

Eye for Pharma hosted its first Patient Centered Clinical Trials symposium in Boston.

The European Forum for GCP and MedTech Europe have established a Medical Technology Working Party.

Select Clinical Trials announced the launch of its website designed to help identify clinical trials for common illnesses and medical conditions

Select Clinical Trials, a public service for all individuals interested in medical research, launched a new website that catalogues leading clinical trials conducted by doctors and healthcare professionals that the public can participate in.

New multi-stakeholder collaboration will drive dialogue on specificities of clinical standards for medical technology

Wingspan Technology released eTMF 2.1 on August 29.

Even though sponsors and CROs are working to create more and more documents as electronic originals, scanned paper still comprises a large portion of any given eTMF.

Wingspan Technology released eTMF 2.1

Industry news focusing on the people and organizations who work in the clinical trials profession.

Almac has combined three pre-existing technologies in one support package.

Almac's clinical Supply Chain Management service combines consultancy and supportive technology that helps sponsor companies

The new Clinical Trials Regulation introduces an overhaul of the existing regulation of clinical trials for medicinal products in the EU.

Implementing a "just-in-time" site activation process effectively can significantly speed trial startup.

It is a tragic truism to remark that the merits of the pharma sector are most sharply perceived only at times of deep human suffering.

The health sciences industry received some important and encouraging news from the US Food and Drug Administration in late June...

ACT TV's video library.

Last August, Quintiles announced its intention to purchase Novella Clinical, specifically for its focus on small and mid-sized oncology biopharma clients, as well as medical device and diagnostics companies.

As pharmaceutical and biotech companies look to speed development, lower cost, and reduce technical risks associated with new drug development, they are increasing the number and types of collaborative relationships they are forming with other developers.

According to Tufts CSDD R&D Management Report, more than half of all new drugs approved in the United States between 2000 and 2011 were developed by companies that collaborated in one form or another with other entities.

ICR has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management.

Fujitsu Limited and the Alliance for Clinical Research Excellence and Safety announced the formation of a Strategic Alliance

As the biopharmaceutical industry continues to move down an outsourcing path, it is essential that logical sourcing strategies and operational processes exists and align with corporate strategy.

Fujitsu and ACRES have linked up to address challenges facing the development of medicines and health-related research endeavors.

While at the 2014 NYBIO conference, Dr. Sam Waksal from Kadmon had the opportunity to address the audience regarding the state of the biopharmaceutical industry.

Pharmaceutical sponsors conducting clinical trials in the Asia Pacific region have a rare opportunity at hand...